Nomination Date: 10/08/2004
Nominator: Private Individual
Rationale: Vioxx, a popular drug used to treat arthritis, was removed from the market when it was discovered that it increased the risk of heart attack and stroke. Two other COX-2 inhibitors, Celebrex & Bextra, should be studied to determine if they have similar side effects.
NTP Principles: not specified
Status: In Review/Pending
Agents and Status
The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.
Agent Name: Celecoxib (celebrex (tm))
Agent Name: Valdecoxib